Lanza is currently based at Ocata Therapeutics in Massachussetts, where he leads their research into stem cells and regenerative medicine. Lanza co-authored a report in the Lancet in October 2014 which claimed that, after two years of testing, embryonic stem cells had proven themselves to be safe to use.
Robert Lanza’s Twitter
Robert Lanza’s official site
Controversial cloning pioneer Robert Lanza on his private island Emily Nathan interviews Lanza at his Massachusetts home.
Is there an afterlife? The science of biocentrism can prove there is,…
Register today to continue reading
You’ve hit your limit of three articles in the last 30 days. To get seven more, simply enter your email address below.
You’ll also receive our free e-book Prospect’s Top Thinkers 2020 and our newsletter with the best new writing on politics, economics, literature and the arts.
Prospect may process your personal information for our legitimate business purposes, to provide you with newsletters, subscription offers and other relevant information.
Click here to learn more about these purposes and how we use your data. You will be able to opt-out of further contact on the next page and in all our communications.
Already a subscriber? Log in here